Financial reports
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
22 Feb 24
8-K
Regulation FD Disclosure
3 Jan 24
8-K
Other Events
9 Nov 23
8-K
Collegium Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
24 Aug 23
8-K
Other Events
7 Aug 23
8-K
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
8-K
Collegium Reports First Quarter 2023 Financial Results
4 May 23
8-K
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
23 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
10 Aug 23
S-8
Registration of securities for employees
11 Aug 22
SC TO-T/A
Third party tender offer statement (amended)
21 Mar 22
SC TO-T/A
Third party tender offer statement (amended)
11 Mar 22
SC TO-T/A
Third party tender offer statement (amended)
4 Mar 22
SC TO-T/A
Third party tender offer statement (amended)
18 Feb 22
SC TO-T
Third party tender offer statement
18 Feb 22
SC TO-C
Information about tender offer
14 Feb 22
S-8
Registration of securities for employees
12 Aug 21
S-8
Registration of securities for employees
13 Aug 20
Proxies
DEF 14A
Definitive proxy
11 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 22
DEF 14A
Definitive proxy
6 Apr 22
DEFA14A
Additional proxy soliciting materials
7 Apr 21
DEF 14A
Definitive proxy
7 Apr 21
DEFA14A
Additional proxy soliciting materials
9 Apr 20
DEF 14A
Definitive proxy
9 Apr 20
PRE 14A
Preliminary proxy
25 Mar 20
DEFA14A
Additional proxy soliciting materials
15 Mar 19
DEF 14A
Definitive proxy
15 Mar 19
Other
EFFECT
Notice of effectiveness
31 Mar 20
CORRESP
Correspondence with SEC
27 Mar 20
UPLOAD
Letter from SEC
23 Mar 20
EFFECT
Notice of effectiveness
7 Nov 19
CORRESP
Correspondence with SEC
1 Nov 19
UPLOAD
Letter from SEC
31 Oct 19
CT ORDER
Confidential treatment order
18 Apr 18
EFFECT
Notice of effectiveness
18 Oct 16
CORRESP
Correspondence with SEC
14 Oct 16
UPLOAD
Letter from SEC
14 Oct 16
Ownership
4
Thomas B Smith
4 Mar 24
144
Notice of proposed sale of securities
29 Feb 24
4
Scott Dreyer
28 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
4
Colleen Tupper
14 Feb 24
4
Scott Dreyer
14 Feb 24
4
Thomas B Smith
14 Feb 24
4
Shirley R. Kuhlmann
14 Feb 24
4
Joseph Ciaffoni
14 Feb 24
SC 13G/A
EVENTIDE ASSET MANAGEMENT, LLC
14 Feb 24